APP and Alzheimer disease: In Alzheimer’s disease (AD), the abnormal accumulation of extracellular beta-amyloid (Abeta) plaques and intracellular hyperphosphorylated tau induces progressive synaptic alterations, axonal dystrophies, neuronal loss and the deterioration of cognitive capabilities of patients [1,2].